IDEAYA Biosciences, Inc. IDYA Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s accrued expenses?
- IDEAYA Biosciences, Inc. (IDYA) reported accrued expenses of $43.75M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s accrued expenses changed year-over-year?
- IDEAYA Biosciences, Inc.'s accrued expenses increased by 32.9% year-over-year, from $32.91M to $43.75M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s accrued expenses has grown at a 369.1% compound annual growth rate (CAGR), from $18K to $40.89M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.